Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19

Fig. 3

Percentage change from baseline to post-acute phase in prescription frequency in the overall population (N = 19,558). Medication classes shown are according to USC designations; included classes are those prescribed to ≥ 2% of the baseline population and with a percentage change from baseline to post-acute phase of ≥ 10%. Percentage changes from baseline to post-acute phase according to age group and disease severity are shown in Table 4, and raw values during baseline and post-acute phases for all medication classes regardless of percentage change are shown for the overall population in Table S3. USC, Uniform System of Classification

Back to article page